Asymptomatic carotid bruit;O sopro carotídeo assintomático

Revista Portuguesa de Cardiologia

Volumn 24, Issue 2, 2005, Pages 285-294

  Fareleira, Filipa ^a   Julião, Miguel ^a   Roque, Andreia ^a   Vaz Carneiro, António ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Carotid atherosclerosis; Carotid bruit; Endarterectomy; Evidence based cardiology; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY BRUIT; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE MARKER; DYSLIPIDEMIA; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; STROKE;

CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 17444373431     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Messina L, Zelenock G, Cerebrovascular Occlusive Disease. In Greenfield L, editor. Surgery: Scientific Principles and Practice. Philadelphia: Lippincott-Raven, 1997:1745.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
3. Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989;80:749-56.
4. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-54.
5. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet 1991;338: 1345-9.
6. Davies KN, Humphrey PR. Do carotid bruits predict disease of the internal carotid arteries? Postgraduate Med J 1994;70:433-5.
7. Chambers BR, Norris JW. Clinical significance of asymptomatic neck bruits. Neurology 1985;35:742-5.
8. Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartil AG, Karp HR, Tyroler HA, Hames CG. Risk of stroke in asymptomatic persons with cervical arterial bruits: a population study in Evans County, Georgia. N Engl J Med 1980;302: 838-41.
9. Wolf PA, Kannel WB, Sorlie P, McNamara P. Asymptomatic carotid bruit and risk of stroke. The Framingham Study. JAMA 1981;245:1442-5.
10. Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986;315:860-5.
11. Autret A, Pourcelot L, Saudeau D, Bertrand P, de Boisvilliers S, Marchai C. Stroke risk in patients with carotid stenosis. Lancet 1987;1:888-90.
12. Diagnostic evaluation of the carotid arteries. Health and Public Policy Committee, American College of Physicians. Ann Intern Med 1988;109:835-7.
13. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-8.
14. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-83.
15. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russell G. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999;319:630-5.
16. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med 2003;348:383-93.
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
18. Kawachi I, Colditz GA, Stampfer MJ, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232-6.
19. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk 1999;6:217-21.
20. Bowman TS, Sesso HD, Ma J, Kurth T, Kase CS, Stampfer MJ, Gaziano JM. Cholesterol and the risk of ischemic stroke. Stroke 2003;34:2930-4.
21. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjekshus J, Kristinsson A, McInnes GT, Mehlsen J, Nieminen MS, O'Brian E, Östergren J, for the ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58.
22. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Int Med 1998;128:89-95.
23. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 1997;278: 313-21.
24. Crouse JR3, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997;157:1305-10.
25. Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM, Shepherd J. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 2001;103:387-92.
26. Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-30.
27. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 2003;163:669-76.
28. Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-67.
29. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569-81.
30. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641-9.
31. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321: 129-35.
32. Cote R, Battista RN, Abramowicz M, Langlois Y, Bourque F, Mackey A. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Int Med 1995;123:649-55.
33. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421-8.
34. Moore WS, Vescera CL, Robertson JT, Baker WH, Howard VJ, Toole JF. Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke 1991;22:1353-7.
35. Dodick DW, Meissner I, Meyer FB, Cloft HJ. Evaluation and management of asymptomatic carotid artery stenosis. Mayo Clin Proc 2004;79:937-44.
36. Whitty CJ, Sudlow CL, Warlow CP. Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful. J Neurol Neurosurg Psychiatry 1998;64:619-23.
37. Perry JR, Szalai JP, Norris JW. Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Arch Neurol 1997;54:25-8.
38. Matchar DB, Pauker SG. Endarterectomy in carotid artery disease. A decision analysis. JAMA 1987;258:793-798.
39. Feussner JR, Matchar DB. When and how to study the carotid arteries. Ann Intern Med 1988;109:805-18.
40. Moore W, editor. A health policy perspective on carotid endarterectomy: cost, effectiveness, and cost-effectiveness. 1996
41. Bogousslavsky J, Despland PA, Regli F. Asymptomatic tight stenosis of the internal carotid artery: long-term prognosis. Neurology 1986;36:861-3.
42. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RKT, Meldrum HE, Barnet HJM, for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. N Engl J Med 2000;342:1693-700.